MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-25-2026
Edwards Lifesciences Corporation Cost of Revenue 2011-2026 | EW
Cost of Revenue is a financial metric that reflects all direct costs associated with the production of goods or the provision of services that directly led to revenue during the reporting period. It is the total amount of expenses incurred by the company to deliver its products or services, including both production costs and related expenses necessary for delivery or customer support.What is included in the cost of revenue
| Cost Category | Examples |
|---|---|
| Production Costs | Materials, wages of production staff, depreciation of equipment |
| Service and Support | Customer service, user support, technical assistance |
| Delivery and Logistics | Packaging, delivery of goods to customers |
| Hosting and Infrastructure | Servers, cloud platforms (especially for IT and SaaS companies) |
| Content and Licenses | License purchases, production royalties (e.g., in streaming services) |
Importance of the Metric
- Helps to understand how costly the revenue-generating process is.
- A high cost of revenue may indicate:
Poor cost control
Low operational efficiency - A low cost of revenue combined with high revenue indicates high profitability and business competitiveness.
Annual Cost of Revenue Edwards Lifesciences Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.33 B | 1.12 B | 978 M | 724 M | 1.25 B | 1.08 B | 1.11 B | 939 M | 875 M | 797 M | 617 M | 626 M | 517 M | 491 M | 490 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.33 B | 490 M | 863 M |
Quarterly Cost of Revenue Edwards Lifesciences Corporation
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 345 M | 344 M | 302 M | - | 263 M | 276 M | 287 M | - | 251 M | 257 M | 330 M | - | 254 M | 269 M | 299 M | - | 312 M | 334 M | 293 M | - | 281 M | 238 M | 265 M | - | 292 M | 304 M | 232 M | - | 225 M | 246 M | 234 M | - | 213 M | 211 M | 216 M | - | 201 M | 202 M | 180 M | - | 147 M | 159 M | 136 M | - | 168 M | 151 M | 146 M | - | 128 M | 124 M | 121 M | - | 112 M | 130 M | 127 M | - | 126 M | 128 M | 117 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 345 M | 112 M | 222 M |
Cost of Revenue of other stocks in the Medical devices industry
| Issuer | Cost of Revenue | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
BioSig Technologies
BSGM
|
57 K | - | 37.08 % | $ 85.7 M |  USA |
 |
Delcath Systems
DCTH
|
11.8 M | $ 9.13 | -0.76 % | $ 327 M | USA |
 |
Axonics Modulation Technologies
AXNX
|
76 M | - | - | $ 3.31 B | USA |
 |
Dynatronics Corporation
DYNT
|
21.4 M | - | 14.99 % | $ 929 K | USA |
 |
Aziyo Biologics
AZYO
|
5.7 M | - | 1.37 % | $ 20.5 M | USA |
 |
Acutus Medical
AFIB
|
10.3 M | - | -26.83 % | $ 2.62 M | USA |
 |
Allied Healthcare Products
AHPI
|
24.5 M | - | 3.58 % | $ 2.21 M | USA |
 |
Conformis
CFMS
|
38.8 M | - | - | $ 16.4 M | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
728 M | $ 9.38 | -1.78 % | $ 722 M | USA |
 |
Cardiovascular Systems
CSII
|
63.4 M | - | 0.15 % | $ 844 M | USA |
 |
Second Sight Medical Products
EYES
|
11.4 M | - | -0.97 % | $ 54.4 M | USA |
 |
Apollo Endosurgery
APEN
|
34.4 M | - | - | $ 475 M | USA |
 |
Inogen
INGN
|
194 M | $ 6.5 | 1.25 % | $ 173 M | USA |
 |
IRIDEX Corporation
IRIX
|
30.1 M | $ 1.35 | 1.89 % | $ 21.8 M | USA |
 |
IRadimed Corporation
IRMD
|
19.5 M | $ 98.74 | -2.99 % | $ 1.26 B | USA |
 |
OrthoPediatrics Corp.
KIDS
|
63.7 M | $ 16.35 | 0.74 % | $ 384 M | USA |
 |
Avinger
AVGR
|
5.65 M | - | -20.74 % | $ 369 K | USA |
 |
LENSAR
LNSR
|
27.6 M | $ 5.52 | -1.08 % | $ 63.6 M | USA |
 |
CONMED Corporation
CNMD
|
624 M | $ 36.64 | -1.19 % | $ 1.14 B | USA |
 |
Medtronic PLC
MDT
|
11.6 B | $ 87.67 | -0.24 % | $ 113 B | USA |
 |
NanoVibronix
NAOV
|
1.05 M | - | - | $ 1.08 M | USA |
 |
Electromed
ELMD
|
14 M | $ 24.45 | -0.85 % | $ 207 M | USA |
 |
Neovasc
NVCN
|
556 K | - | - | $ 111 M |  Canada |
 |
Orthofix Medical
OFIX
|
256 M | $ 11.79 | -1.17 % | $ 467 M |  Curacao |
 |
Outset Medical
OM
|
72.7 M | $ 3.52 | -0.28 % | $ 53.5 K | USA |
 |
Cytosorbents Corporation
CTSO
|
10.5 M | $ 0.6 | -10.61 % | $ 32.7 M | USA |
 |
Aethlon Medical
AEMD
|
3.87 M | $ 2.27 | -2.16 % | $ 3.54 M | USA |
 |
PAVmed
PAVM
|
6.42 M | $ 8.94 | -3.87 % | $ 64.7 M | USA |
 |
BIOLASE
BIOL
|
32.4 M | - | -13.19 % | $ 166 K | USA |
 |
LivaNova PLC
LIVN
|
448 M | $ 63.65 | 0.55 % | $ 3.47 B |  Britain |
 |
InspireMD
NSPR
|
6.33 M | $ 1.73 | -2.26 % | $ 111 M |  Israel |
 |
Insulet Corporation
PODD
|
768 M | $ 218.11 | 0.98 % | $ 15.3 B | USA |
 |
AdaptHealth Corp.
AHCO
|
2.64 B | $ 11.41 | 0.18 % | $ 1.54 B | USA |
 |
Quanterix Corporation
QTRX
|
73.9 M | $ 3.9 | -1.52 % | $ 166 M | USA |
 |
Penumbra
PEN
|
461 M | $ 336.42 | 0.04 % | $ 13.1 B | USA |
 |
MiMedx Group
MDXG
|
73 M | $ 3.94 | -3.9 % | $ 582 M | USA |
 |
Invacare Corporation
IVC
|
566 M | - | - | $ 24.7 M | USA |
 |
Ra Medical Systems
RMED
|
161 K | - | 10.0 % | $ 610 K | USA |
 |
Myomo
MYO
|
14 M | $ 0.68 | -2.2 % | $ 28.5 M | USA |
 |
Inspire Medical Systems
INSP
|
133 M | $ 50.45 | -1.87 % | $ 1.48 B | USA |